Nutanix Inc. diskutieren
Nutanix, Inc. (NASDAQ: NTNX) had its price target lowered by analysts at Barclays PLC from $80.00 to $71.00. They now have an "overweight" rating on the stock.
Ratings data for NTNX provided by MarketBeat
Nutanix, Inc. (NASDAQ: NTNX) had its price target lowered by analysts at Bank of America Co. from $75.00 to $72.00. They now have a "buy" rating on the stock.
Ratings data for NTNX provided by MarketBeat
Neueste Beiträge
Stifel_Nicolaus in BioMarin Pharmaceutical Inc. diskutieren